A method for determining presence of lymphoma in a patient is disclosed. A sample of bone marrow, thymus, spleen, lymph nodes, lymph and/or lymphocytes taken from the patient t is assayed to determine expression of CDK9 and CYCLIN T1. The presence of CDK9 and/or CYCLIN T1 is indicative of a lymphoma other than a mantle cell lymphoma or marginal zone lymphoma in the patient.
Giordano, A., Tosi, P. (2006)"Methods for determining presence of cancer by analyzing the expression of cyclin-dependent kinase 9 (CDK9) and /or cyclin T1 in lymphoid tissue.". . Brevetto No. WO2006017239A1.
"Methods for determining presence of cancer by analyzing the expression of cyclin-dependent kinase 9 (CDK9) and /or cyclin T1 in lymphoid tissue."
GIORDANO, ANTONIO;TOSI, PIERO
2006-01-01
Abstract
A method for determining presence of lymphoma in a patient is disclosed. A sample of bone marrow, thymus, spleen, lymph nodes, lymph and/or lymphocytes taken from the patient t is assayed to determine expression of CDK9 and CYCLIN T1. The presence of CDK9 and/or CYCLIN T1 is indicative of a lymphoma other than a mantle cell lymphoma or marginal zone lymphoma in the patient.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
WO2006017239A1.pdf
non disponibili
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
1.42 MB
Formato
Adobe PDF
|
1.42 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/974387